IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v42y2019i3d10.1007_s40264-018-0731-6.html
   My bibliography  Save this article

Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy

Author

Listed:
  • Su Golder

    (University of York)

  • Stephanie Chiuve

    (AbbVie)

  • Davy Weissenbacher

    (University of Pennsylvania)

  • Ari Klein

    (University of Pennsylvania)

  • Karen O’Connor

    (University of Pennsylvania)

  • Martin Bland

    (University of York)

  • Murray Malin

    (AbbVie)

  • Mondira Bhattacharya

    (AbbVie)

  • Linda J. Scarazzini

    (AbbVie)

  • Graciela Gonzalez-Hernandez

    (University of Pennsylvania)

Abstract

Introduction Adverse effects of medications taken during pregnancy are traditionally studied through post-marketing pregnancy registries, which have limitations. Social media data may be an alternative data source for pregnancy surveillance studies. Objective The objective of this study was to assess the feasibility of using social media data as an alternative source for pregnancy surveillance for regulatory decision making. Methods We created an automated method to identify Twitter accounts of pregnant women. We identified 196 pregnant women with a mention of a birth defect in relation to their baby and 196 without a mention of a birth defect in relation to their baby. We extracted information on pregnancy and maternal demographics, medication intake and timing, and birth defects. Results Although often incomplete, we extracted data for the majority of the pregnancies. Among women that reported birth defects, 35% reported taking one or more medications during pregnancy compared with 17% of controls. After accounting for age, race, and place of residence, a higher medication intake was observed in women who reported birth defects. The rate of birth defects in the pregnancy cohort was lower (0.44%) compared with the rate in the general population (3%). Conclusions Twitter data capture information on medication intake and birth defects; however, the information obtained cannot replace pregnancy registries at this time. Development of improved methods to automatically extract and annotate social media data may increase their value to support regulatory decision making regarding pregnancy outcomes in women using medications during their pregnancies.

Suggested Citation

  • Su Golder & Stephanie Chiuve & Davy Weissenbacher & Ari Klein & Karen O’Connor & Martin Bland & Murray Malin & Mondira Bhattacharya & Linda J. Scarazzini & Graciela Gonzalez-Hernandez, 2019. "Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy," Drug Safety, Springer, vol. 42(3), pages 389-400, March.
  • Handle: RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0731-6
    DOI: 10.1007/s40264-018-0731-6
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-018-0731-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-018-0731-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Bissan Audeh & Florelle Bellet & Marie-Noëlle Beyens & Agnès Lillo-Le Louët & Cédric Bousquet, 2020. "Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project," Drug Safety, Springer, vol. 43(9), pages 835-851, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0731-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.